DeutschNewstral
Article
jdsupra.com on 2018-02-12 21:54
Significant New York Drug and Device 2017 Product Liability Decisions
Related news
- Product Liability Alert: Failure-To-Warn Suit Against Generic Drug Maker Proceeds Despite Argument of Federal Preemptionjdsupra.com
- Pharmaceutical Product Liability Class Action Filed Relating to Olmetec Drugjdsupra.com
- Product Liability Hopping & the FDA’s Generic Drug Proposal – Awful Togetherjdsupra.com
- Proposed New FDA Labeling Rules Would Result in Increased Generic Drug Product Liability Claimsjdsupra.com
- FDA Issues Warning Letter for Unapproved Medical Device for Significant Product Quality and Corrective Action-Related Violationsjdsupra.com
- FDA Issues Final Guidance on Benefit-Risk Factors to Consider in Medical Device Product Availability, Compliance, and Enforcement Decisionsjdsupra.com
- Summary of FDA Draft Guidance: Factors to Consider Regarding Benefit-Risk in Medical Device Product Availability, Compliance, and Enforcement Decisionsjdsupra.com
- [Video] Anticipating When the FDA Will Treat Your Product as a Drug-Device Combinationjdsupra.com
- Is it a drug, device, biologic, or combination product? FDA issues final guidance on classificationjdsupra.com
- Product Liability Update - July 2021jdsupra.com
- Product Liability Update - September 2023jdsupra.com
- Product Liability Update - May 2020jdsupra.com
- Product Liability Update - January 2023jdsupra.com
- Product Liability Update: October 2020jdsupra.com
- Product Liability Update - August 2020jdsupra.com
- Product Liability Update - October 2022jdsupra.com
- Product Liability Update - April 2024jdsupra.com
- Product Liability Update - April 2023jdsupra.com
- Product Liability Update - January 2024jdsupra.com
- What About Me? Liability Considerations and Protections For Businesses Outside the Drug and Device Space in the COVID-19 Erajdsupra.com